(HealthDay News) — For patients with chronic kidney disease (CKD) and congestive heart failure (CHF) undergoing coronary procedures, central venous pressure (CVP)-guided hydration is associated with reduced risk of contrast-induced nephropathy (CIN), according to a study published online in JACC: Cardiovascular Interventions.

Geng Qian, MD, from the Chinese People’s Liberation Army General Hospital in Peking, and colleagues conducted a prospective comparative trial involving 264 patients with CKD and CHF undergoing coronary procedures. Patients were randomized to CVP-guided hydration or standard hydration (132 patients in each group). The hydration infusion rate was dynamically adjusted according to CVP level every hour in the CVP-guided group.

The researchers found that the total mean volume of isotonic saline administered was significantly higher in the CVP-guided hydration group than the control group (P < 0.001). CIN occurred less often in the CVP-guided hydration group (15.9 versus 29.5% in the control group; P = 0.006). There was no difference between the groups in the incidences of acute heart failure during the hydration (3.8 versus 3.0%; P = 0.500).

Continue Reading

“CVP-guided fluid administration can safely and effectively reduce the risk of CIN in patients with CKD and CHF,” the authors write.


  1. Qian G, Fu Z, Guo J, Cao F, and Chen Y. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure–Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients. J Am Coll Cardiol Intv. doi:10.1016/j.jcin.2015.09.026.
  2. Solomon R. Improving Intravenous Fluid Therapy for Prevention of Contrast-Induced Nephropathy How to Give More Without Causing Heart Failure. J Am Coll Cardiol Intv. doi:10.1016/j.jcin.2015.10.014.